NTRA: Natera Inc. Stocks News on September 7, 2024

NTRA

Insider Monkey

a day ago

What Makes Natera (NTRA) an Investment Bet?

NTRA

Insider Monkey

5 days ago

Natera (NTRA) Rose After Revenues And Profit Margins Beat Estimates

NTRA

Insider Monkey

7 days ago

Billionaire Stan Druckenmiller Is Betting On Natera, Inc. (NTRA)

Natera to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

NTRA

Business Wire

10 days ago

Natera to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Exploring Three High Growth Tech Stocks in the United States

NTRA

Simply Wall St.

11 days ago

Exploring Three High Growth Tech Stocks in the United States

PepsiCo, Inc. (PEP): Among Morgan Stanley’s Highest Conviction Stocks

NTRA

Insider Monkey

11 days ago

PepsiCo, Inc. (PEP): Among Morgan Stanley’s Highest Conviction Stocks

NTRA

Insider Monkey

11 days ago

Natera, Inc. (NTRA): Among Morgan Stanley’s Highest Conviction Stocks

NTRA

GuruFocus.com

22 days ago

Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)

NTRA

MT Newswires

25 days ago

Natera's H2 Guidance Leaves 'Ample Room' for Upside, Morgan Stanley Says

NTRA

Simply Wall St.

25 days ago

Natera, Inc. (NASDAQ:NTRA) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates

Natera Second Quarter 2024 Earnings: EPS Beats Expectations

NTRA

Simply Wall St.

a month ago

Natera Second Quarter 2024 Earnings: EPS Beats Expectations

NTRA

GuruFocus.com

a month ago

Decoding Natera Inc (NTRA): A Strategic SWOT Insight

NTRA

Thomson Reuters StreetEvents

a month ago

Q2 2024 Natera Inc Earnings Call

NTRA

Zacks

a month ago

Compared to Estimates, Natera (NTRA) Q2 Earnings: A Look at Key Metrics

NTRA

Associated Press Finance

a month ago

Natera: Q2 Earnings Snapshot

NTRA

MT Newswires

a month ago

Natera Q2 Loss Narrows, Revenue Jumps

Natera Reports Second Quarter 2024 Financial Results

NTRA

Business Wire

a month ago

Natera Reports Second Quarter 2024 Financial Results

Natera to Participate in the Canaccord Genuity 44th Annual Growth Conference

NTRA

Business Wire

a month ago

Natera to Participate in the Canaccord Genuity 44th Annual Growth Conference

Natera to Report its Second Quarter 2024 Results on August 8, 2024

NTRA

Business Wire

a month ago

Natera to Report its Second Quarter 2024 Results on August 8, 2024

Natera touts positive results for Merkel cell carcinoma surveillance test

NTRA

Medical Device Network

a month ago

Natera touts positive results for Merkel cell carcinoma surveillance test

NTRA

GuruFocus.com

a month ago

Insider Sale: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)

New MultiCenter Prospective Study Demonstrates Signatera’s Clinical Utility in Merkel Cell Carcinoma

NTRA

Business Wire

a month ago

New MultiCenter Prospective Study Demonstrates Signatera’s Clinical Utility in Merkel Cell Carcinoma

NTRA

Zacks

a month ago

Natera (NTRA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

NTRA

GuruFocus.com

2 months ago

Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)

NTRA

Insider Monkey

2 months ago

Natera (NTRA) Soared After a 43% Increase In Revenue

Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy

NTRA

Business Wire

2 months ago

Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy

NTRA

Simply Wall St.

2 months ago

Natera's (NASDAQ:NTRA) investors will be pleased with their massive 314% return over the last five years

NTRA

GuruFocus.com

2 months ago

Insider Sale: CEO and President Steven Chapman Sells 37,500 Shares of Natera Inc (NTRA)

Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer

NTRA

Business Wire

2 months ago

Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer

NTRA

GuruFocus.com

3 months ago

Insider Selling: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)

NTRA

MT Newswires

3 months ago

Natera Adds New Feature to Prospera Heart Test to Improve Detection of Rejection in Transplant Patients

Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients

NTRA

Business Wire

3 months ago

Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients

Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

NTRA

Business Wire

3 months ago

Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

NTRA

Insider Monkey

3 months ago

Natera (NTRA) Raised Initial 2024 Guidance in Q1

NTRA

GuruFocus.com

3 months ago

Director Gail Marcus Sells 2,000 Shares of Natera Inc (NTRA)

NTRA

GuruFocus.com

3 months ago

Director Rowan Chapman Sells Shares of Natera Inc (NTRA)

NTRA

Business Wire

3 months ago

Natera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024

Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference

NTRA

Business Wire

3 months ago

Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference

Natera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual Meeting

NTRA

Business Wire

3 months ago

Natera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual Meeting

NTRA

GuruFocus.com

4 months ago

Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)

NTRA

GuruFocus.com

4 months ago

Decoding Natera Inc (NTRA): A Strategic SWOT Insight

Why Natera Is 'A Stock To Focus On' Following Its Mighty Beat-And-Raise

NTRA

Investor's Business Daily

4 months ago

Why Natera Is 'A Stock To Focus On' Following Its Mighty Beat-And-Raise

Stocks to Watch Friday: TSMC, Novavax, Nvidia, Goldman Sachs

NTRA

The Wall Street Journal

4 months ago

Stocks to Watch Friday: TSMC, Novavax, Nvidia, Goldman Sachs

NTRA

GuruFocus.com

4 months ago

Natera Inc (NTRA) Surpasses Analyst Revenue Forecasts in Q1 2024

NTRA

Associated Press Finance

4 months ago

Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024

NTRA

Insider Monkey

4 months ago

Natera, Inc. (NASDAQ:NTRA) Q1 2024 Earnings Call Transcript

Natera Stock Charges Higher. Positive Cash Flow Arrived Early.

NTRA

Barrons.com

4 months ago

Natera Stock Charges Higher. Positive Cash Flow Arrived Early.

NTRA

Associated Press Finance

4 months ago

Natera: Q1 Earnings Snapshot

Natera Reports First Quarter 2024 Financial Results

NTRA

Business Wire

4 months ago

Natera Reports First Quarter 2024 Financial Results

New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast Cancer

NTRA

Business Wire

4 months ago

New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast Cancer

NTRA

GuruFocus.com

4 months ago

Insider Sale: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)

NTRA

GuruFocus.com

4 months ago

Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)

Natera to Report its First Quarter 2024 Results on May 9

NTRA

Business Wire

4 months ago

Natera to Report its First Quarter 2024 Results on May 9

Natera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage

NTRA

Business Wire

4 months ago

Natera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage

Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc

NTRA

GuruFocus.com

4 months ago

Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc

10 Cathie Wood Stocks Insiders are Selling

NTRA

Insider Monkey

4 months ago

10 Cathie Wood Stocks Insiders are Selling

NTRA

Insider Monkey

4 months ago

Natera (NTRA) Rose on Momentum in the Oncology Market

NTRA

GuruFocus.com

4 months ago

Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)

NTRA

GuruFocus.com

4 months ago

CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)

Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications

NTRA

Business Wire

5 months ago

Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications

NTRA

GuruFocus.com

5 months ago

Insider Sell: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)

NTRA

Simply Wall St.

5 months ago

Estimating The Fair Value Of Natera, Inc. (NASDAQ:NTRA)

Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation

NTRA

Business Wire

5 months ago

Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation

NTRA

Insider Monkey

5 months ago

11 Best Biotech ETFs To Buy

Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients

NTRA

Business Wire

5 months ago

Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients

Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer

NTRA

Business Wire

5 months ago

Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer

NTRA

Insider Monkey

5 months ago

Is Natera (NTRA) On The Cusp Of Being Cash Flow Positive?

NTRA

GuruFocus.com

5 months ago

Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)

Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer

NTRA

Business Wire

5 months ago

Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer

NTRA

Insider Monkey

6 months ago

11 Best Healthcare ETFs To Buy Now

NTRA

Insider Monkey

6 months ago

Will Natera (NTRA) Continue to Deliver Solid Topline Growth?

Genetic Testing Stock Nears Buy Point After Earnings Gap-Up And 45% Gain

NTRA

Investor's Business Daily

6 months ago

Genetic Testing Stock Nears Buy Point After Earnings Gap-Up And 45% Gain

Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal Cancer

NTRA

Business Wire

6 months ago

Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal Cancer

New KDIGO Guideline Supports Genetic Testing for the Majority of CKD Patients to Establish Cause of Disease

NTRA

Business Wire

6 months ago

New KDIGO Guideline Supports Genetic Testing for the Majority of CKD Patients to Establish Cause of Disease

Natera to Present New Data at the 2024 SGO Annual Meeting on Women’s Cancer, Following Recent Medicare Coverage Decisions in Ovarian and Breast Cancers

NTRA

Business Wire

6 months ago

Natera to Present New Data at the 2024 SGO Annual Meeting on Women’s Cancer, Following Recent Medicare Coverage Decisions in Ovarian and Breast Cancers

NTRA

GuruFocus.com

6 months ago

SEC and Chief Legal Officer Daniel Rabinowitz Sells Shares of Natera Inc (NTRA)

Natera Announces Commercial Coverage for Prospera™ Kidney and Prospera Heart™ from a Top BCBS Plan

NTRA

Business Wire

6 months ago

Natera Announces Commercial Coverage for Prospera™ Kidney and Prospera Heart™ from a Top BCBS Plan

NTRA

Zacks

6 months ago

What Makes Natera (NTRA) a Strong Momentum Stock: Buy Now?

Natera Full Year 2023 Earnings: Beats Expectations

NTRA

Simply Wall St.

6 months ago

Natera Full Year 2023 Earnings: Beats Expectations

NTRA

GuruFocus.com

6 months ago

Decoding Natera Inc (NTRA): A Strategic SWOT Insight

NTRA

Thomson Reuters StreetEvents

6 months ago

Q4 2023 Natera Inc Earnings Call

NTRA

Insider Monkey

6 months ago

Natera, Inc. (NASDAQ:NTRA) Q4 2023 Earnings Call Transcript

Natera to Participate in March Investor Conferences

NTRA

Business Wire

6 months ago

Natera to Participate in March Investor Conferences

NTRA

Zacks

6 months ago

Compared to Estimates, Natera (NTRA) Q4 Earnings: A Look at Key Metrics

NTRA

GuruFocus.com

6 months ago

Natera Inc (NTRA) Reports Significant Revenue Growth and Improved Gross Margins in Full Year 2023

Natera Reports Fourth Quarter and Full Year 2023 Financial Results

NTRA

Business Wire

6 months ago

Natera Reports Fourth Quarter and Full Year 2023 Financial Results

NTRA

Insider Monkey

6 months ago

Natera (NTRA) Management Increased Full Year Guidance

Natera Announces Next Phase of CareDx Patent Infringement Litigation Seeking Royalty For All Ongoing And Future AlloSure Tests

NTRA

Business Wire

6 months ago

Natera Announces Next Phase of CareDx Patent Infringement Litigation Seeking Royalty For All Ongoing And Future AlloSure Tests

Natera secures Medicare coverage for cancer test in 2 new indications

NTRA

MedTech Dive

6 months ago

Natera secures Medicare coverage for cancer test in 2 new indications

Medicare Extends Coverage of Natera’s Signatera™ MRD Test to Ovarian Cancer and Neoadjuvant Breast Cancer

NTRA

Business Wire

6 months ago

Medicare Extends Coverage of Natera’s Signatera™ MRD Test to Ovarian Cancer and Neoadjuvant Breast Cancer

Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call

NTRA

Business Wire

7 months ago

Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call

Natera Inc Director Herm Rosenman Sells 93,901 Shares

NTRA

GuruFocus.com

7 months ago

Natera Inc Director Herm Rosenman Sells 93,901 Shares

3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List

NTRA

InvestorPlace

7 months ago

3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List

New Study Validates Signatera™ in Endometrial Cancer

NTRA

Business Wire

7 months ago

New Study Validates Signatera™ in Endometrial Cancer

Insider Sell: CFO Michael Brophy Sells 22,281 Shares of Natera Inc

NTRA

GuruFocus.com

7 months ago

Insider Sell: CFO Michael Brophy Sells 22,281 Shares of Natera Inc

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NTRA

Business Wire

7 months ago

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quest Diagnostics (DGX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

NTRA

Zacks

7 months ago

Quest Diagnostics (DGX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Insider Sell: CFO Michael Brophy Sells 3,235 Shares of Natera Inc

NTRA

GuruFocus.com

7 months ago

Insider Sell: CFO Michael Brophy Sells 3,235 Shares of Natera Inc

AMH Announces Tax Treatment of 2023 Distributions

NTRA

PR Newswire

7 months ago

AMH Announces Tax Treatment of 2023 Distributions

New Publication Demonstrates Signatera’s Ability to Risk Stratify and Detect Recurrence Early in Resected Stage I-II Lung Cancer

NTRA

Business Wire

7 months ago

Latest Natera Inc. (NTRA) News on September 7, 2024

Share on Social Networks: